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Abstract
Background: Human natural killer (NK) cells are the key contributors of innate immune response and
the effector functions of these cells are enhanced by cytokines such as interleukine 2 (IL2). We utilized
genome-wide transcriptional profiling to identify gene expression signatures and pathways in resting and
IL2 activated NK cell isolated from peripheral blood of healthy donors.
Results: Gene expression profiling of resting NK cells showed high expression of a number of cytotoxic
factors, cytokines, chemokines and inhibitory and activating surface NK receptors. Resting NK cells
expressed many genes associated with cellular quiescence and also appeared to have an active TGFβ
(TGFB1) signaling pathway. IL2 stimulation induced rapid downregulation of quiescence associated genes
and upregulation of genes associated with cell cycle progression and proliferation. Numerous genes that
may enhance immune function and responsiveness including activating receptors (DNAM1, KLRC1 and
KLRC3), death receptor ligand (TNFSF6 (FASL) and TRAIL), chemokine receptors (CX3CR1, CCR5 and CCR7),
interleukin receptors (IL2RG, IL18RAB and IL27RA) and members of secretory pathways (DEGS1, FKBP11,
SSR3, SEC61G and SLC3A2) were upregulated. The expression profile suggested PI3K/AKT activation and
NF-κB activation through multiple pathways (TLR/IL1R, TNF receptor induced and TCR-like possibly
involving BCL10). Activation of NFAT signaling was supported by increased expression of many pathway
members and downstream target genes. The transcription factor GATA3 was expressed in resting cells
while T-BET was upregulated on activation concurrent with the change in cytokine expression profile. The
importance of NK cells in innate immune response was also reflected by late increased expression of
inflammatory chemotactic factors and receptors and molecules involved in adhesion and lymphocyte
trafficking or migration.
Conclusion: This analysis allowed us to identify genes implicated in cellular quiescence and the cytokines
and cytotoxic factors ready for immediate immune response. It also allowed us to observe the sequential
immunostimulatory effects of IL2 on NK cells improving our understanding of the biology and molecular
mediators behind NK cell activation.
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Background
Natural killer (NK) cells are the crucial mediators of
immune reponse against tumor cells and pathogens via
modulating both innate and adaptive immune response
[1-3]. They can either directly kill the tumor derived or
virus infected cells, enhance the phagocytic or bactericidal
activity of phagocytes or direct adaptive T cell response
towards the Th1 pattern [4,5]. NK cells constitute around
10% of peripheral blood lymphocytes and are character-
ized phenotypically by surface expression of CD56 and
CD16 but not CD3. The majority of NK cells (90%) are
CD56dimCD16bright – and mediate cytolytic activity against
tumor or pathogen-infected cells whereas the remaining
(10%) are cytokine producing NK cells with a
CD56brightCD16dim/negativephenotype[6]. These NK subsets
also express distinct chemokines that are important in
their preferential localization within the lymphatic system
[7].
The killing of target cells by NK cells is based on two alter-
native pathways, namely the perforin/granzyme secretory
pathway and the death receptor pathway [8]. The secre-
tory pathway can lyse target cells via spontaneous or anti-
body-dependent cell-mediated cytotoxicity (ADCC).
Spontaneous cytotoxicity is initiated by ligand binding to
activating NK receptors resulting in sequential recruit-
ment and activation of SRC and SYK kinases, PI3K, RAC1,
PAK1, MEK and ERK, leading to Perforin 1 and Granzyme
B granule polarization and movement toward the ligated
target cell [9]. ADCC killing involves the low affinity
receptor for IgG on NK cells, CD16 (FcγRIII). The interac-
tion of CD16 with IgG coating the target cells leads to sig-
naling through FcεRIγ and CD3ζ resulting in cytotoxic
granule polarization and possible activation of VAV, PI3K
and PLC-γ2 [10]. The death receptor pathway is based on
the interaction between NK surface-bound ligands such as
TNFSF6 (FASL) and TRAIL or NK-secreted factors such as
TNFα, LTA and LTB [11] with death receptors on the target
cells thereby triggering a signaling cascade resulting in
apoptosis of the targeted cells.
The cytokine producing NK cells are important in early
innate immune response, where the release of cytokines
and chemokines stimulates and recruits other cells.
Response of the NK cells themselves is under the control
of signaling events primed by activating and inhibiting
surface receptors. These include different members of the
human killer cell immunoglobulin-like receptors (KIR),
the C-type lectin receptor families (Ly49 (KLRA1),
CD159A (KLRC1), CD159c (KLRC2), NKG2E (KLRC3),
CD94 (KLRD1), CLEC5C (KLRF1) and NKG2D (KLRK1))
and the natural cytotoxicity receptors (NKp46, NKp44
and NKp30) [12]. Immune response of NK cells is also
under the influence of cytokines such as IFNα, IFNβ, IL2,
IL12, IL15 and IL18 secreted by other cells of the immune
system. IL2 is a pluripotent cytokine that can expand and
activate NK cells [13] as well as promote their migration
within target tissues [14], their cytotoxicity [15] and
increase the secretion of cytokines, chemokines and other
small molecules [16]. The molecular mechanisms under-
lying this classical NK cell activator for increased NK cell
activity have not been elucidated.
We performed gene expression profiling on resting and in
vitro IL2 activated human NK cells to increase our under-
standing of the molecular events important in NK cell
activation. Increased knowledge of the mechanisms con-
trolling chemokine and cytokine expression, cellular
migration and IL2 mediated signal transduction pathways
may help to enhance, re-direct or modify the immune and
anti-tumor activity of NK cells and provide a valuable
platform for the study of NK cell derived malignancies.
We discuss the induction of novel signal transduction
pathways during the NK cell activation and validate some
of the differentially expressed genes by RT-PCR. The
impact of the observed transcriptional profile in orches-
trating the innate immune responeby NK cell is also dis-
cussed.
Results
General approach on time-dependent gene expression 
analysis of NK cells stimulated with IL2
The aim of the study was to investigate the activation of
human NK cells by IL2 through analyzing the global gene
expression at different time points (0, 2, 8 and 24 hours)
after culture with the cytokine IL2 at 100 IU/ml. NK cells
with the CD56+/CD16+ and CD3- phenotype were nega-
tively selected by immunomagnetic beads and re-exam-
ined by flow-cytometry to ensure greater than 90% purity
(Figure 1). Equivalent amount of total RNA from NK cells
derived from 3 or 4 different donors for each time point
was pooled, amplified and labeled before duplicate
hybridizations was performed on spotted (pre-synthe-
sized oligonucleotide) microarrays (additional file 1). To
validate the gene expression data, a different set of exper-
iments with 6 other individual donors was performed.
RNA was similarly extracted and pooled from 4 different
donors, amplified and labled according to the manufac-
turer's instruction (GeneChipU133plus2®, Affymetrix Inc,
CA). The expression data generated from microarray
experiments were uploaded in BRB-ArrayTool[17,18] to
obtain the functional annotations of the geneID or probe
sets and their normalized data were used for further anal-
ysis. Of the 54,676 probe sets represented on
GeneChipU133plus2® with 20,585 unique genes, 62 %
(~12,750) of the genes were also represented on the spot-
ted microarray. Only pathways showing a similar pattern
of expression on the two platforms were selected for fur-
ther analysis and a few of the genes were also validated by
RT-PCR (Figure 5).BMC Genomics 2007, 8:230 http://www.biomedcentral.com/1471-2164/8/230
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Resting NK cell signature
The resting NK cell signature from the spotted microarray
was defined as differentially expressed genes, that had ≥ 2
fold higher expressions in resting NK cells compared to
the lymphoid RNA standard and also ≥ 2 fold higher
expression than tonsillar cells and resting CD8+ T cells.
Thus, 1027 transcripts were included in the resting NK cell
signature on the spotted array platform (additional file 2).
The NK cell signature derived from the
GeneChipU133plus 2® was based on similar comparisons,
with the modification that, tonsil profile was replaced
with an universal RNA standard (Stratagene Inc, CA). In
this format, 1133 unique transcripts were overexpressed
in resting NK cells (additional file 3). Comparison of the
NK cell signatures from the two platforms resulted in a
common set of 164 genes (Table 1). The genes included
inhibitory NK cell surface molecules, activating NK cell
surface molecules as well as cytotoxic mediators. Many
genes encoding chemokines, cytokines and their receptors
and genes involved in secretory functions were also
expressed at high levels in resting cells. We also examined
a curated resting NK signature from the literature (Signa-
ture Data-base) [19] derived from the Affymetrix platform
[20]. Thirty-three of sixty genes (55%) were found in our
Affymetrix derived signature, (additional file 4), demon-
strating consistency within the individual platform.
Temporal analysis of the IL2 stimulated NK cells
Self organizing maps (SOM) generated from spotted
microarray data identified the differentially expressed
genes that had at least a 2-fold alteration in expression
level between the time points analyzed (additional file 5).
The expression of the selected pathways was examined
and cross-validated on both platforms. Additional genes
on Affymetrix microarray platform
(GeneChipU133plus2®) belonging to functional groups
that were determined to be differentially expressed were
included for more comprehensive interpretation.
Cytolytic pathway
The mRNA of a number of molecules associated with
cytolytic function were expressed in resting NK cells
(Granzyme K (GZMK), Cathepsin O (CTS0), -K (CTSK), -S
(CTSS) and -Z (CTSZ)), but they were rapidly downregu-
lated upon stimulation with IL2. A rapid induction of
other molecules involved in granule mediated cytotoxicity
were detected concurrently (Granzyme B (GZMB), Granu-
lysin (GNLY), Perforin 1(PRF1), Cathepsin D (CTSD),
Cathepsin C (CTSC/DPP1) and TIA1). Late activation was
observed for Granzyme A (GZMA), -M (GZMM), -H
(GZMH), Cathepsin W (CTSW), -B (CTSB) and -F (CTSF)
(Figure 2A and additional file 6(A)).
Many members of the TNFSF and TNFRSF were upregu-
lated early. Some affecting the death receptor apoptotic
pathway (TNFSF6  (FASL) and TNFSF10 (TRAIL)) and
others probably activating the NF-κB pathway (TNFRSF1B
(TNFRB), TNFRSF14, TNFRSF4, TNFα (late activated) and
TRADD (late activated)). Of interest was TNFSRF14, which
can interact with several members of TRAFs to activate
innate immune response in concordance with increased
expression of several members of the TRAF family (1, 2, 3,
5 and 7). In addition, a group of of dipeptidylpeptidases
(DPP 1, 3, 7 and 8) (DPP4 and 10 in additional file 6(A)),
most of which are serine proteases involved in cleaving
proline adjacent bonds, showed increased expression
mainly at 8–24 hours. The well characterized DPPs impli-
cated in cytolysis are DPP1 (Cathepsin C/CTSC), involved
Flow cytometry analysis of NK cells isolated from PBMC by negative selection Figure 1
Flow cytometry analysis of NK cells isolated from PBMC by negative selection. The purity of NK cells was assessed using fluo-
rescence-labeled antibodies to CD3, CD16 and CD56. A. NK cells not stained with specific antibodies (isotype control). B. NK 
cells labeled with mAb for CD3 (Alexa 488) and CD56 (Alexa 647). C. NK cells labeled with mAb for CD3 (Alexa 488) and 
CD16 (Alexa 647). Less than 1% CD3 positive cells are present and > 94% of the cells are CD3- CD56+ while > 93% are CD3- 
and CD16 +.
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in processing of GZMA, -B and DPP4 (CD26), a serine
protease involved in CD16 mediated cytolysis by NK cells
[21].
Cytokines, chemokines and their receptors
A few chemokine ligands and receptors showed high
expression in resting cells (CXCR4 and CCL28) (Figure
2B) likely related to the immediate immune response of
NK cells. A group of chemokine receptors (CCR7, CCR1,
CXCR3, CMKOR1 (CXCR7) and CX3CR1) showed an
early increased expression after IL2 stimulation. Later a
large number of chemokines and a few chemokine recep-
tors (CCL3, CCL4, CCL5, Chemokine- like factor superfamily
members (CKLFSF6, -8, -3, -7 and -4), CCR5, CCR6 and
CXCR6) showed increased expression at 8–24 hours (Fig-
ure 2B). The increased expression of these genes is likely
responsible for the proinflammatory response of NK cells,
including the recruitment of NK cells as well as other
immune cells to sites of inflammation. Many interferons
and interferon induced genes were upregulated (IFNγ,
IFN induced protein 44 like (IFI44L), IFNγ inducible protein
16(IFI16), IFN regulatory factor 6 (IRF6), -2, -7, IFNA16, -
4, IFNAR1, -2, IFN induced protein 35 (IFI35), -44, -30, IFN
induced protein with tetratricopeptide repeats 1 (IFIT1), IFIT3
and IFIT5) (Figure 2B). Some of the interleukins (IL8, -18
and -24) and interleukin receptors (IL7R, -21R, -12RB1, -
8RB and -11RA) were highly expressed in resting cells and
decreased upon IL2 stimulation. Others were upregulated
on IL2 stimulation (LTA (TNFB), IL2Rα, IL2Rβ, IL18R1,
IL17RB, IL12RB2, IL17R, IL2RG, IL15, IL32/NK4, IL16,
IL27RA, IL15RA and IL18RAP) (Figure 2B). This profile of
IL and ILR expression suggests that resting NK cells are
ready for immediate immune response by secreting a
number of cytokines. After activation, many ILRs were
expressed, indicating that activated NK cells show
enhanced sensitivity to autocrine and/or paracrine stimu-
lation by other cells recruited to the site of inflammation.
Secretory signature
The transport of nascent polypepetides synthesized in the
endoplasmic reticulum (ER) to the Golgi apparatus is an
important step in the secretion of mature proteins
through exocytosis. Proper folding and appropriate mod-
ifications are also crucial steps in protein secretion. The
Table 1: Resting NK signature derived from Affymetrix and spotted microarray platform.
Median fold change (Range)
Gene ontogeny Gene symbols Spotted Affymetrix
Cell cycle regulators BTG1, JAG1, MATK, TGFBR3, TINF2, TMEPAI, NEK1, CCND2, CCNC, 
BIN1, HEXIM1, PPP2R5A, CARF
2.59 (2.01–5.06) 3.76 (2.87–7.05)
Cytotoxicity CRTAM, CTSW, DPP8, FASLG, FNBP1, GNLY, GZMA, GZMH, HCST, 
LITAF, PRF1, TNFRSF1B, TNFSF14, NEK1, CASP10, STK17B, CTSC, 
PRSS23
4.48 (2.36–12.76) 4.43 (2.8–19. 42)
Cytokines CCL5, CX3CR1, IL18R1, IL18RAP, IL21R, PPBP(CXCL7) 7.12 (2.9–17.56) 5.93 (2.86–29.7)
Inflammatory response C3AR1, PDE7A, LY75, RORA, AOAH, ARF6, C1orf38, CLEC2B, IRF1 3.12 (2.20–6.56) 5.06 (2.83–11.01)
Regulators of immune 
response 
PTPN4(negative regulators), PPP2R2B, SLA2, ID2, KLF11, ZFHX1B 3.18 (2.36–8.6) 9.92 (2.84–11.39)
Secretory pathway and 
protein maturation 
GALNT11, GNPTAB, RAMP1, SEC22L3, SLC38A1, TES, TPST2, 
WDFY1, GALNT7, DNAJC3, SLC35E1, ZNF12
3.88 (2.90–9.01) 4.34 (3.00–4.96)
Transcription factors and 
accessory regulators 
BHLHB2, EOMES, KBTBD2, MAF, NFAT5, THRAP3, TXK, ZBTB11, 
ZNF267, ZNF394, ZNF12, HCF2, MLLT10, MLL3, SSRPN, TAF1, 
MLR1, ZNF614, EIF2C4, EIF1AY, EIF2C2,
3.55 (2.58–7.44) 3.71 (2.88–4.9)
Regulation of GTPase activity CENTD1, PLEK, PREX1, RAB7L1, RASGRP1, RGS18, RGS3, RIN3, 
PCTK2, RAB27B
4.16 (2.91–5.67) 4.43 (3.64–6.8)
Proliferative GFI1, SMAD5, ZBTB16, AKT3, SMC5L1, RNF139 2.90 (2.90–22.16) 3.02 (3.02–5.3)
Cytoskeleton orgnisation DOCK5, DOCK8, DOK2, MACF1, MYOM2, PHLDB2 3.41 (2.73–6.21) 3.51 (2.94–8.50)
Metabolism and nucleotide 
biosynthesis 
DCY7, ATP6AP2, CHST12, CLIC3, GFOD1, PARP8, TKTL1, YPEL1, 
ENPP4, DHRS7, BPGM
2.92 (2.25–19.24) 4.98 (2.84–9.55)
Miscellaneous SBK1, PLAC8, PLCL2, RNF125, SPAG9, MAPK1, C10orf137, C10orf18, 
C1orf63, C20orf3, FLJ13611, FLJ39739, GALNT10, ZBTB11, BTBD9, 
C14orf43, BRWD1, FAM62B, BCAP29, C18orf8, LOC285628, 
KLHL21, KIAA0907, KIAA1450, MOBKL2A, TSPYL1, TRIM39, ULK2, 
ULK4, WAC, YTHDC2, ZSWIM6
4.16 (2.42–10.13) 4.23 (2.94–8.17)
Cell adhesion and cell surface ITGAM, ITGB2, ADAM8, FGR, CD300A(Irp60), CD3Z, CD96, FCER1G, 
CD94 (KLRD1), CD314 (KLRK1), LAIR2, ADD3, CD244, SPN(CD43), 
KLRF1
3.36 (2.36–8.9) 3.90 (2.4–21.53)
Resting NK signature of genes showing 2 fold higher expression levels on two microarray platforms. A common set of 164 genes were more than 2 
fold higher expressed in resting NK cells compared to 1) the lymphoid RNA standard, tonsillar cells and resting CD8+ T cells on spotted 
microarrays and 2) the lymphoid RNA standard, universal RNA standard (Stratagene Inc, CA) and resting CD8+ T cells on GeneChipU133plus 2® 
(Affymetrix Inc, CA).BMC Genomics 2007, 8:230 http://www.biomedcentral.com/1471-2164/8/230
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gene profiles showed upregulation of large groups of
genes involved in secretory functions. Many genes
involved in modifications or modulations of proteins
affecting their stability and activity were upregulated early
(2 hours) (DEGS1, PPP2CB and MGAT2) and later (8–24
hours)(FKBP11) (Figure 2C and additional file 6(B)). A
large group of genes involved in vesicle trafficking in the
ER (SSR3, SEC61G, 61A1, -24C and -23B), post processing
in ER for optimal enzyme activity (CDKN3 late) and cargo
import to Golgi apparatus (SLC3A2, -33A1, -30A5, -1A4,
COPE and VDP) were upregulated (Figure 2C). In the late
phase of activation (24 hours), genes required for protein
transport to specific destinations (SRP9, SSR1, -4,
RABAC1  and  SPCS3), proper protein folding (EDEM,
HSPA5 and TXNDC5), modification (DAD1, RPN1 and
DDOST) and receptor mediated processing (PPIB) were
overexpressed.
Cell surface/adhesion molecules
On IL2 stimulation, activating NK cell receptors or co-
receptors (CD226 (DNAM1), NKp44 (NCR2), NKp30
(NCR3), CD314 (KLRK1), KLRB1, KLRC3 and KLRC1)
showed increased expression and NK inhibitory receptors
(KIR2DL2, -DL3, DL1, KIR2DS4, -DS5, KIR3DL3, -DL1
and -DL2) showed decreased expression (Figure 3A).
However, it was not a universal shift towards an upregula-
tion of activating receptors as some of the activating NK
receptors (NKp46 (NCR1), CD160 (By55), KLRC4 and
KLRF1) had dimished expression in activated cells. There
was also increased expression of some inhibitory recep-
tors (CD300A (IRp60), KIR2DL4 and KLRG1). A number
of transcripts (CD3Z, CD6, CD8A, CD97, CD58, CD56
(NCAM1), CD102 (ICAM2), CD44, CD38 and CD47)
were upregulated at 2–8 hours. The expression of these
genes is generally related to lymphocyte activation or lym-
phocyte trafficking and cell adhesion. Many integrins
(ITGAV, ITGA6, -4, -B3, ITGAM, ITGAX, ITGB2 and
ITGB1) and other adhesion molecules (CD302, ICAM1,
CD208 (ICAM3) and CD81) had high expression in rest-
ing cells which are likely important for NK cell homing.
The late induced (24 hours) surface molecules included
CD96 (NK cell activating receptor TACTILE), CD63 (Granu-
lophysin),  integrin alpha L (ITGAL) and  integrin-β7
Functional groups of genes with maximal differences in expression levels between resting NK cells (column1) and NK cells  after 2, 8 or 24 hours (colums 2,3 & 4 respectively) of IL-2 activation are shown Figure 2
Functional groups of genes with maximal differences in expression levels between resting NK cells (column1) and NK cells 
after 2, 8 or 24 hours (colums 2,3 & 4 respectively) of IL-2 activation are shown. The color change in each row represents the 
gene expression relative to the median across the samples and values are visualized according to the scale bar that represents 
the expression fold difference (log2) relative to the median. A) Cytolytic pathway, B) Cytokines, chemokines and their recep-
tors, and C) Secretory signature.
Cytokines, chemokines  and their receptors  Secretory signature     (C)
*
*= CXCR7
*
< -4         -2               0             2         4 >
(B) Cytolytic pathway         (A)
= DR5
= TRAIL
alpha
= TNFRSF6
= TNFSF6
= DPP1
= DR4
=NK4
Fold-change compared to the medianBMC Genomics 2007, 8:230 http://www.biomedcentral.com/1471-2164/8/230
Page 6 of 17
(page number not for citation purposes)
(ITGB7), that are all important for adhesive interaction of
NK cells during immune responses.
Cell cycle and proliferation
In freshly isolated NK cells, there was high expression of a
group of genes that had cell cyle regulating functions (Fig-
ure 3B). Thus, there was high expression of inhibitory
interaction partners of CDKs (CDKN1B (p27) that pre-
vents the activation of cyclin E-CDK2 or cyclin D-CDK4
complexes,  CDKN2D (p19) inhibitor of CDK4 and
CDK5RAP1, inhibitor of CDK5). Other negative cell cycle
regulators (CCNG2, CCNG1 associated with G2/M phase
arrest in response to DNA damage and Cullins (CUL5, -
4A, -2 and -3)) had increased expression suggesting a tight
control of cell cycle progression in the resting circulating
NK cells of peripheral blood. A few activators were also
present (CDK5R1 (p35) activator of CDK5, CDK7  that
together with CCNH  (high in resting cells) and MAT1
functions as a CDK-activating kinase (CAK) and CCNC
that interacts with CDK8) (Figure 3B). In keeping with the
postulate, these inhibitory genes showed rapid downreg-
ulation upon IL2 activation. Concomitantly, there was an
early (2 hours) increase in expression of genes involved in
regulating general transcription, initiation/regulation of
DNA replication, DNA repair and translation control
(Cullin1, CDK8, RAD17, GTF2H1 and TFDP1)(Figure 3B
and additional file 6(C)(TFDP2)). Numerous genes
involved in the G1/S phase of the cell cycle (inhibitors:
CDKN1A (p21) and BCCIP; activators CDC2, -7 and -6),
members of cell cycle transcriptional regulators (E2F fam-
ily member 1, -2, -3, RB1 and RBL2)(RBL1 additional file
6(C)), and associated proteins (CDK8, -4, -2 and 6) and
many  cyclins (D3, B1, E2, B2 and  D2) showed an
increased expression at 8–24 hours. A family of genes cru-
cial for DNA replication in the S-phase (MCM2,-3,-4 and
-6)(MCM5, additional file 6(C)) showed maximum
expression at 24 hours. Most of the M phase and anaphase
regulators were not upregulated. Interestingly, a few genes
involved in the late phases of of cell cycle: anaphase pro-
moting control (ANAPC4) and kintechore associated gene
(KNTC1) were highly expressed by 24 hours, suggesting
that they may serve some different functions at earlier
phases of the cell cycle. The proliferation marker PCNA
showed high expression by 24 hours (Figure 3B and addi-
tional file 6(C)).
Signal transduction
JAK/STAT pathway
Cytokine signals mediating control of cell growth and sur-
vival often involve the JAK/STAT pathway. Thus, addition
Differential gene expression between resting NK cells (column1) and NK cells after 2, 8 or 24 hours (colums 2, 3 & 4 respec- tively) of IL-2 activation are shown Figure 3
Differential gene expression between resting NK cells (column1) and NK cells after 2, 8 or 24 hours (colums 2, 3 & 4 respec-
tively) of IL-2 activation are shown. A) Cell surface and adhesion molecules B) Cell cycle, proliferation and quiescence (See also 
figure 2 legend for details)
Cell surface and adhesion molecules (A)
= CD56
=2B4A
= NKp44
= NKp30
= DNAM1
=TNFRSF5
=By55
)
(B) Cell cycle, proliferation (left panel) and quiescence (right panel)
=p27
=p19
=p21
< -4         -2              0             2         4 >
Fold-change compared to the medianBMC Genomics 2007, 8:230 http://www.biomedcentral.com/1471-2164/8/230
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of IL2 to resting NK cells in culture induced upregulation
of an important upstream member of this pathway (JAK3)
and major substrates (STAT4 and -5A [early phase], STAT1
and -6 [late phase]) and trancriptional mediators of STATs
(MCM5 and NMI)(Figure 4A and additional file 7(A)).
Several negative regulators of the JAK/STAT pathway:
supressors of cytokine signaling (SOCS3  and  -6) were
downregulated after 2 hours with IL2 stimulation,
whereas others (PIAS2, -4 and SOCS7) were upregulated.
Activation of JAK2 and JAK3 in response to IL2 in NK cells
has been reported previously and implicated in the activa-
tion of STAT4 and STAT5, respectively [22-24]. These
observations are in agreement with our findings that 7 of
8 STAT4 target genes (when CCL3 is included) examined
and 8 of 9 STAT5 targets (additional file 7(A)) showed
increased expression in IL2 stimulated cell. Examination
of the targets of STAT1 showed an increase in 13 of 15 tar-
get genes. The transcript levels of JAK1, STAT3 and STAT2
did not show a consistent pattern on the two platforms
and they were not analyzed further.
TGFβ pathway
Transforming growth factor-β (TGFβ/TGFB1) pathway
regulates diverse cellular function through SMAD pro-
teins, which regulate transcription through their interac-
tion with other transcription factors and the recruitment
of co-repressors or co-activators depending on the cellular
and functional context. Three members of TGFB1 type II
receptors (BMPRIA (ALK3), BMPR2 (t-ALK) and
ACVR2A), several ligands (BMP2,  INHBC  and  TGFB1
(TGFβ)) and many members of the SMAD family (R-
Smad (SMAD5), Co-Smad (SMAD4)  and I-Smad
(SMAD7)) were upregulated in resting NK cells (Figure
4B). We also observed increased expression of SMAD4
interacting coactivators (EP300, DCP1A, and PCQAP)
and marginal decrease in co-repressor TGIF expression in
resting cells. SMAD ligases (SMURF1) and associated pro-
Signaling pathways Figure 4
Signaling pathways. A) JAK/STAT pathway, B) TGFB1 pathway, C) PI3K-activation pathway, D) NFAT activation pathway, E) I: 
NF-κB pathway regulation and II: NF-κB target genes. (See also figure 2 legend for details)
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teins (RUNX1 and RUNX2) showed increased expression
in resting cells. The elaboration of TGFB1 protein by rest-
ing NK cells has been well documented and the downreg-
ulation of TGFβ pathway in NKcells activated by
proinflamatory cytokines (24–48 stimulated hours) has
also been observed by others [25]. We also observed a
change in the expression profile of transcripts on this
pathway on IL2 activation with downregulation of many
of the transcripts mentioned above and upregulation of
receptors (TGFBR1,TGFBR2  and  TGFBR3) and the R-
SMAD (SMAD2) in activated NK cells. SMAD3 showed
brief marginal repression upon IL2 activation (2 hours),
but upregulation in late activated cells (24 hours). Some
negative regulators also seemed to be active in resting cells
but examination of the target genes of TGFβ/SMADs
showed high expression in 6 out of 7 genes. Thus, it
appears that resting NK cells have an active TGFB1 signal-
ing pathway involving at least SMAD4 and SMAD5
instead of SMAD2, features that are similar to signaling
mediated by other members of the TGFβ superfamily,
namely the BMPs [26]. An active TGFβ pathway may be
important in maintaining growth arrest through inhibi-
tion of granulocyte-macrophage-colony-stimulating fac-
tors (GMCSF) [27] or induction of p21 and p15, in
addition to the negative modulation of pro-inflammatory
and cytolytic activites [25,28].
PI3K- pathway activation
Upon IL2 stimulation of NK cells, signal transduction
from tyrosine phosphorylation of the IL2Rβ chain results
in activation of the PI3K signaling pathway [29]. Three
genes encoding PI3K catalytic subunits had highest
expression levels after 2 hours (PIK3CA, PIK3CD and
PIK3CG), while the transcript encoding the β-subunit
showed a slower rise (PIK3CB). This increased PI3K
expression occurred even though the negative regulator of
the pathway, the phosphatase PTEN [30] showed progres-
sively increased expression in the stimulated cell (Figure
4C and additional file 7(B)). PI3K activation enhances
cell survival and antagonizes apoptosis via AKT of which
subtypes (AKT1 and -2) became upregulated by IL2. Acti-
vated AKT inhibits apoptosis by phosphorylating BAD
that is part of the BAD/BCLXL complex. Phosphorylated
BAD dissociate from the BAD/BCLXL complex, thereby
promoting cell survival. This correlates well with down-
regulated AKT target genes that are crucial for cell cycle
regulation e.g. the FOXO genes (3A and 1A) responsible
for promoting quiescence [31] and p27, a cell cycle inhib-
Confirmation of the microarray analysis with real time quantitative RT-PCR Figure 5
Confirmation of the microarray analysis with real time quantitative RT-PCR. The differential expression of some transcripts 
that have no previous reported association with NK biology were further validated by a real time quantitative RT-PCR. Tem-
poral changes in the expression of selected genes from (A) Gene downregulated on IL2 activation (B) early upregulated genes 
(2 hours) and (C) late upregulated genes (8–24 hours).
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itor. In addition, AKT activates EIF4E, a promoter of pro-
tein synthesis through mTOR and EIF4E had increased
expression in activated cells. PI3K can also regulate cyto-
toxicity by activation of the RAC1, PAK1, MEK1/2
(MAP2K2) and ERK1/2 (MAPK1) pathways [9]. The
expression of all these genes was upregulated in activated
cells. Since AKT1and -2, RAC1, PAK1, MEK1/2 (MAP2K2)
and ERK1/2 (MAPK1) were upregulated and FOXO3A, -
1A and p27 were downregulated in our study, it is likely
that PI3K influences several pathways simultaneously
affecting cell survival, cell cycling and cytotoxicity.
NFAT activation in NK cells
The activation of NFAT is regulated by Ca2+ /calcineurin
dependent signaling and has been implicated in the secre-
tion of various cytokines upon CD16 ligand binding in
NK cells [32]. The transcriptional activity of NFAT can be
activating or inhibitory, depending on the co-factors,
including AP1(Fos/Jun), MEF2, GATA and histone
deacetylases (HDACs). Among the five members of the
NFAT family, only NFAT5  showed upregulation at the
early phase of IL2 stimulation in both platforms (2
hours)(Figure 4D), similar to the report by Jin et.al (see
figure 3B in [33]). In T cells, NFAT activation is mediated
through the CD3ζ and CD3γ of the TCR and regulated by
the phosphatase calcineurin. Calcineurin can dephospho-
rylate NFAT (1–4) proteins, leading to their nuclear
import and DNA binding. The increased expression of
CD3ζ, positive regulators of intracellular Ca2+  release
(PLCγ 1 and  -γ2), catalytic calcineurin A subunits (α
(PPP3CA),β (PPP3CB) and γ (PPP3CC)) and kinases for
NFAT nuclear shuttling (GSK3B, CK2(CSNK2A1) and
JNK) in activated NK cells suggested the induction of
NFAT signaling on IL2 stimulation. Concordant with the
above changes, we observed downregulation of crucial
inhibitors (SLA and PTPRC (CD45)) of this pathway in
activated cells. Several target genes were upregulated at
different time points (Figure 4D), e.g. FASL, IL2RB,
CX3CR1 (Figure 2B) and TGFB1 at 2 hours and IFNγ, p21
(CDKN1A) and TNF2 at 24 hours. A recent study showed
that IL2 can induce CX3CR1 expression through NFAT2
(NFATC1) binding to its promoter, whereas IL15
represses it through induction of NFAT1 [34]. This obser-
vation indicates that NFAT1 (NFATC2) and NFAT2
(NFATC1) may have opposite roles in the expression of
some genes in NK cells. NFATC1 (NFAT2) interacts with
GATA3 [35], the major T-cell transcriptional regulator,
that was highly expressed in resting NK cells as in naïve T
cells and was downregulated on IL2 stimulation. T-BET
(T-box expressed in T cells) on the other hand showed
increased expression with IL2 stimulation. GATA3 is a
Th2-regulating transcription factors that promotes the
expression of IL4 and IL5, while T-BET is a Th1-specific
transcription factor that controls the expression of CCR5,
IFNG and IL18R1, all of which increased in activated NK-
cells. These transcription factors may have similar roles in
NK cells. T-BET is also required for terminal maturation
and peripheral homeostasis of NK cells [36].
NF-κB pathway regulation
Resting cells have high expression of the NF-κB family
genes (REL, RELA (NFKB3 or p65), RELB and  NF-κB1
(p105)), some members of toll-like receptor (TLR) and
IL1R pathway (Figure 4E, I and additional file 7(C)).
Upon activation, maintained or increased expression of
these transcripts was seen and many additional transcripts
of different NF-κB activating signaling pathways were
upregulated. Thus, in the TLR/IL1R pathway increased
expression was observed for TLR2 and adaptor proteins
(Myd88, TIRAP, TICAM1 and TICAM2), adaptor kinases
(IRAK1, -2 and -3), kinase interacting protein (Tollip) and
the kinases TAK1(MAP3K7) and TAB2(MAP3K7IP2) that
activate the IKK complex. Members of the TNF receptor
super family (TNFRSF10A (death receptor 4) and TNFRSF6
(FAS)), their adaptors protein (TRADD) and associated
protein (TRAF5) also showed upregulation in activated
cells suggesting TNF receptor mediated NF-κB activation
since TRAF5 can recruit the IΦB kinases (IKKα, -β and -γ)
to the TNF receptor complex, where RIP can activate the
IKK catalytic subunits (IKKα and -β) through
MAP3Kinases (Figure 4EI and additional file 7(C)). Fur-
thermore, some of the positive regulators of the NF-κB sig-
naling cascade in T cells through TCR signaling were also
observed to be upregulated during both the early and late
phase of IL2 stimulation. These included the kinases
(PKCθ and PDPK1) involved in the activation of CARMA1
(CARD11) that leads to the phosphorylation of BCL10
(early down, then increasing) whereas the other essential
component in T and B-cell antigen receptor mediated acti-
vation of NF-κB [37], MALT1 decreased. Since the expres-
sion of BCL10 varied between the two platforms the
upregulation of BCL10 was confirmed by RT-PCR (Figure
5).
This upregulation of many genes in three different
upstream pathways suggested multiple signals converged
in the activation of the NF-κB pathway, perhaps exerting
different influence at different time points. The down-
stream components of the pathway, which include NF-κB
transcripts (NF-κB1 (NFKB1 or p105), NF-κB2 (NFKB2 or
p52/100) and RelB) were also increased at 2 hours. NF-κB
activity is negatively regulated by the binding of inhibi-
tory proteins (IκB) of which NF-κBIA and -Z (IκBα and -
ζ) showed decreased expression in activated cells, how-
ever NF-κBIA showed increased expression at 24 hours
which correlated with the fact that NF-κB induces IκBα
expression [38] (Figure 4E and 5). Phosphorylation of the
IκB proteins by the serine-kinase complex (IκBKα
(CHUK) IκBKβ, IκBKγ and IκBKε) marks them for
destruction, thereby allowing the nuclear localization ofBMC Genomics 2007, 8:230 http://www.biomedcentral.com/1471-2164/8/230
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the NF-κB dimers. Of these kinases IκBKβ  and  IκBKε
showed marked increased expression whereas IκBKα
(CHUK) and IκBKγ showed decreased expression in acti-
vated cells. Activation of NF-κB is supported by the expres-
sion of many target genes in IL2 stimulated cells at one or
more time points (Figure 4E II and additional file 7(C)II).
Interestingly, some of these genes showed high expression
in freshly isolated cells. It is possible that the pathway was
partially activated in resting cells, but it is also possible
that some of the genes might be activated through the
manipulation involved in the isolation of the NK cells.
The expression of some NF-κB target genes e.g ICAM-1,
IκBa, CCR5 and FASL was confirmed by RT-PCR (Figure
5).
Discussion
A gene expression signature of resting NK cells from the
peripheral blood of healthy donors and the changes in
transcriptional profiles upon IL2 activation were obtained
to overview the functional pathways underlying the bio-
logical properties of these cells. Others have addressed IL2
activation of NK cells for fixed time points of 4 hours [39]
or 14 days with multiple activating stimuli with IL2, PHA
and feeder cells [40] whereas our study is directed at early
temporal regulation of pure NK cell activation. Our time
course experiments demonstrated that IL2 exerts a broad
range of effects on NK cells ranging from regulation of cell
cycle, cell survival, cytotoxicity and secretion of immuno-
logic and inflammatory effectors in a sequential manner.
The use of two microarray platforms and independent NK
cell populations validated the generated expression pat-
terns and the biological properties that they suggested.
Observed discrepancies between the two platforms indi-
cate that technical variables and platform specific factors
influence the large scale transcriptional profiles and
sounds cautionary note for efforts to interpret differential
gene expression. The technical variables include RNA
amplifications protocols, which may also influence the
gene expression profile [41]. We have used very strict cri-
teria in our comparative analysis of the two platforms to
attend greater accuracy but this approach may lead to the
lost of some information. However, the basic information
generated from these platforms correlates well when gene
signatures and biological pathways rather than single
genes were compared. It is also important to keep in mind
that high expression of components of a signaling path-
way does not indicate activation of that pathway which
may involve phosphorylation, specific intracellular local-
ization or other posttranslational determinants. On the
other hand, when group of genes subserving specific func-
tional activities show altered expression patterns, it is
indicative perturbation of the pathway in response to a
given stimulus.
Resting NK cells are characterized by a set of genes that
maintain the cells at quiescent state as exemplified by the
expression of FOXO3A, SLA, KLF9 (BTEB1), PNRC1 and
BTG1 (Figure 3B right panel). An interesting finding is the
high expression of many SMADs suggesting an active
TGFβ pathway that may be part of the mechanism main-
taining the resting profile and controlling the effector
function of the NK cells. That these transcripts are
involved in maintaining NK cells in the quiescent state is
also supported by their rapid downregulation on IL-2
stimulation.
High expression of other effector-transcripts like cytotoxic
effectors, cytokines and chemokines, NK receptors,
unique surface markers and adhesion molecules illus-
trated the potential of circulating NK cells of the periph-
eral blood to catalyze and participate in the immediate
immune responses. The presence of mRNAs encoding lig-
ands like CCL5, CXCL7, TNFSF14, FASL and CCL4 might
contribute to the killing of targets, activating other inflam-
matory cells and maintaining the circulating NK popula-
tion in this reactive-prepared condition by autocrine
stimulation loops. Thus, the CCR5 ligands CCL5  and
CCL4 that are expressed in the resting NK cells may act
directly on the growth and survival of neighboring NK
cells expressing CCR5 at the initiation phase of an innate
immune response. Such an autocrine loop is observed for
CCL5-CCR5 in prostate cancer [42]. The effector expres-
sion profiles shift when the cells are stimulated and more
receptor transcripts are expressed preparing the circulating
NK cells to take on other functional roles and adapt to
increased paracrine stimulation from other infiltrating
immune cells.
Another interesting observation is the high expression of
GATA3 in resting NK cells, similar to observation in rest-
ing T cells [43]. T-BET, on the other hand, had low expres-
sion in resting NK cells. There is evidence that both
GATA3 and T-BET are important in the development of
NK cells [36,44] but they may also be important in the
function of mature NK cells. GATA3 is downregulated in
Th1 cells, but its expression is maintained in Th2 cells.
This raised the intriguing possibility that downregulation
of GATA3 and upregulation of T-BET (Th1-specific tran-
scription factor) in IL2 stimulated NK cells is required for
the elaboration of Th1 type of cytokines in activated NK
cells. Together with the decreased expression of GATA3,
activated NK cells appear to change to a more Th1-like
expression profile. While IL2 is a well known Th1 activa-
tor, a similar role has not previously been reported or
observed for NK cells. The regulation of the transcrip-
tional profiles of pro and anti inflammatory cytokines
and chemokines through these transcription factors is an
interesting area of future investigation.BMC Genomics 2007, 8:230 http://www.biomedcentral.com/1471-2164/8/230
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Stimulation of resting NK cells with IL2 triggered an expres-
sion pattern consistent with the NK cells as important
mediators of pro-inflammatory and innate immune
response. Hence, the pro-inflammatory cytokines like
IFNγ, CCL5, CCL4, LTA and  CCL3  were upregulated
whereas anti-inflammatory cytokines and receptors like
IL18BP  and  TNFRSF1B  [45,46] were downregulated.
Combined with the activated innate immune response
mediated by increased TLR signaling (TLR2, Myd88,
TIRAP, TICAM1, TICAM2, IRAK1, -2 and -3, Tollip, TRAF6,
TAK1(MAP3K7)  and  TAB2(.MAP3K7IP2)  and the
enhanced direct (GZMA, PRF1, GZMB, GNLY and
TNFSF6 (FASL)) and indirect ERK enhanced (PI3Ks, AKTs,
RAC1 and MEK2 (MAP2K2)) NK cell cytotoxicity [9] the
stimulation of the circulating NK cells resulted in a signif-
icant shift in transcript profile reflecting the cells adapting
to new functional roles. Strikingly, the cytolytic profile
exhibited by activated NK cells resemble closely that of
IL2 activated CD8+ T-cells [33]. In CD8+ T-cells, the cyto-
toxic effectors in granules (GZMB, GNLY and PRF1) and
TNF family members (FAS, LTA, TRAIL and TNF-α) were
induced whereas GZMK and CD27 (TNRSF7) were down-
regulated after 4 hours of stimulation (300 IU/ml IL2)
(see figure 5B in [33]). In our study, the above mentioned
genes were also upregulated but CD27 showed upregula-
tion at 24 hours.
IL2 stimulation mediated early activation of the JAK/STAT sig-
naling pathway (upregulated JAK3, STAT3, STAT4,
STAT5A, and STAT1) hence affecting down stream tran-
scription of many target genes (Figure 4A). When we
examined STAT target gene expression, many targets of
STAT1, -4 and -5 are upregulated providing confirmatory
evidence of STAT1, -4 and -5 activation. Upregulation of
JAK3, STAT-1, 3, and 5A was also observed by Jin and col-
leagues with purified CD8+ and CD4+ T cells stimulated
with IL2 [33], indicating a common usuage of the JAK/
STAT pathway in the activation in these cells, at least ini-
tially (see figure 1 in [33]). In our study the inhibitors of
JAK/STAT signaling (PIAS1, -2, SOCS3, -5 and -6) were
downregulated but PIAS3, -4 and SOCS7 were upregu-
lated illustrating a balance that may limit the degree of
JAK/STAT activation. IL2 can also activate the Ras-->RAF--
>MEK-->ERK signaling pathway via JAK phosphorylation
of SHC leading to stimulation of proliferation in T cells
[47]. This may happened in NK cells and this is suggested
by our study by the observed upregulated MEK2
(MAP2K2) and ERK1 (MAPK1).
Powerful pro-survival signals were induced by IL2
Four different genes of the PI3K family were upregulated
as were the three isoforms of AKT kinases and simultane-
ously there was decreased expression of the AKT target
genes (FOXO1A, -3A and p27). Together with the facts
that activated AKT promotes cell survival through 1) phos-
phorylation dependent dissociation of the BAD/BCLXL
complex [48] (Bad upregulated) and 2) activation of NF-
κB through phosphorylation of IKK-β [49] (IKKβ upregu-
lated) IL2 induced PI3K resulted in the expression pat-
terns of transcripts that appear to promote survival and
proliferation. Interestingly, when CTLs were simulated in
the presence of other cells in PBMC, the upregulation of
both PI3K and AKT were not detected[33] even though
IL2 induced a general T cell activation and anti-apoptotic
effect illustrating the importance of interactions between
effector and bystander cells. Our study was focused on
purified NK cells and the effects of bystander cells will not
be observed.
NF-κB activation could be mediated by pathways other
than IL2 induced PI3K activation, namely the TLR/IL1R
pathway, the TNF pathway and possibly a NK specific sur-
face receptor pathway involving BCL10. We have
observed good evidence of NF-κB activation through the
first two pathways. It is well established that in both T and
B cells, BCL10 specifically mediate antigen receptor-
induced NF-κB activation [37] In NK cells, BCL10 has
been observed in the cytoplasm of normal NK cells, and
in the nuclei of tumor cells of nasal NK/T-cell lymphomas
[50]. Since we observed upregulation of BCL10, NF-κB1
and NF-κB2 upon stimulation of NK cells with IL2, it is
possible that cytokine receptor mediated signaling also
involve BCL10. The expression pattern of CARD11, a par-
ticipant in BCL10 induced NF-κB activation in T and B
cells [51] also supports this idea. In support of NF-κB acti-
vation was the upregulation of NF-κB1, NF-κB2 and the
upregulation NF-κB target genes (Figure 4E II). In CD8+T
cells, Jin et.al observed increased expression of several
mediators of NF-κB pathway, possibly through modula-
tion of TCR signaling (see figure 3 in [33])
Activation of NFAT signaling pathway
PI3K can promote NFAT nuclear accumulation in two
ways: by enhancing Ca2+ mobilization and calcineurin-
dependent NFAT dephosphorylation leading to nuclear
import, or by AKT-mediated inactivation of GSK-3 that
can phosphorylate NFAT and drive nuclear export [52].
The increased expression of positive regulators of intracel-
lular Ca2+ release, activators of calcineurin, catalytic cal-
cineurin A subunits and kinases for NFAT nuclear
shuttling in activated NK cells suggested both mecha-
nisms to be involved in the NFAT signaling induced by
IL2. NFATC1  showed highest expression in resting NK
cells, similar to a prior observation in resting T cells, where
it is the predominant NFAT protein [53]. NFATC1 inter-
acts with GATA3 to maintain the differentiated Th2 phe-
notype [35]. This supports the notion of suppressed
expression of Th1 type cytokines in resting NK cells. The
profile shifted with the downregulation of GATA3 and
upregulation of T-BET on activation.BMC Genomics 2007, 8:230 http://www.biomedcentral.com/1471-2164/8/230
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Temporal pattern of transcript expression
The early increase in transcription (within the first 2
hours) is likely regulated directly by signaling events –
"first wave" induced transcription. Genes that were upreg-
ulated only after 8–24 hours are likely to represent activa-
tion of "second wave" genes and these were numerous in
our study and especially represented genes involved in
adhesion, secretory pathway, cytotoxicity and cell cycle
control. These "second wave" transcripts are probably
under the control of upstream genes or induced by factors
such as cytokines or chemokines that are elaborated by
the cells at a later time point as illustrated by general
upregulation of target genes of STAT1 and NF-κB. Many
genes had expression patterns where transcript levels were
upregulated at 2 hours, low at 8 hours and then high again
at 24 hours (genes important for cytotoxicity (TIA1 and
PAF1), cytokine signaling (IL2RA and IL18R1), secretory
signaling (SLC3A2, HM13 and DEGS1), cell cycle regula-
tion (MCM6 and CCND2)). The control of transcription
of these genes is more complex and may involve feedback
inhibition or the induction of inhibitors. Time course
experiments are therefore important to gain a more com-
plete picture of the biology and function of the cell of
interest.
The effect of IL2 on cytotoxic cells have been reported by
several groups [16,33,39,54,55] showing many similari-
ties as well as differences. For example, CD8+ T cells stim-
ulated with 300 IU/ml of IL2 for 4 hours either alone or
cocultured with PBMC upregulate IL7, IL13, TNFα and
IFNγ whereas the NK cells in our study did not express IL7
or IL13, and the upregulation of TNFα and IFNγ was reg-
istered at 8 hours. The cytokine profile of activated NK
cells showed marked differences with that observed in
activated CD8+T cells by Jin et.al[33], with the exception
of a few genes (e.g. downregulation of IL8 and CXCR4,
and upregulation of IL15 and IFN-γ). A few chemokines
e.g.CCL3 and CCL4 were only observed to be upregulated
at 24 hours in activated NK cells, whereas in CD8+ T cells,
these chemokines are upregulated early (4 hours). On the
other hand CCL5, IL16 and CXCR3 were downregulated
in isolated CD8+ T cells, but upregulated in NK cells. In
general, a detailed comparison is very difficult because of
the different systems used and the different time point at
which the assays were performed. The expression of many
of the genes are highly variable over a 24 hr period so
there is a significant degree of uncertainty when compared
with results from a particular time point.
In most of the studies, the ethnic composition of the sub-
jects studied was not specified but a systematic compari-
son of two ethnic groups was performed by Jin and co-
workers [33]. The latter study is important in highlighting
racial differences in immune response and may provide
insight into the differences in disease susceptibility and
response to immune modulation.
Conclusion
In conclusion, our study demonstrated gene expression
profiles associated with IL2 induced increased cytotoxic-
ity, changes in chemokines, cytokines and adhesion prop-
erties, enhanced pro-inflammatory and innate immune
response and changes in signaling pathways in NK cells.
The changes in chemotactic signaling and surface/adhe-
sion profile may enable the IL2 activated NK cells to
migrate and infiltrate tissues where inflammation occur
and upon arrival recruit other effector cells of the immune
system. At the same time, NK cells may be more respon-
sive and involved in both autocrine and paracrine signal-
ing in the local environment than previously recognized.
There is good evidence indicating NF-κB activation which
may play a central role in pro-survival and pro-inflamma-
tory function in activated NK cells. The role TGFβ in main-
taining cell quiescence, GATA3/T-BET as master regulators
of transcription of pro- and anti-inflammatory cytokines
and BCL10 in NF-κB activation are intriguing and merit
further investigation. NFAT signaling pathway also
appears to have a functional role in IL2 stimulated NK
cells. Future investigations including the interactions with
other immune cells would provide a more complete pic-
ture of the possible changes of GEP on activation in vari-
ous in vivo situations. Comparison of different ethnic
groups especially with SNP data will allow better under-
standing of normal and disordered immune response.
Methods
Cell extraction and stimulation
Primary NK cells were isolated from seven healthy donors
and each time point contained NK cells from 3 or 4 differ-
ent donors (additional file 8). The healthy donors pro-
vided peripheral blood mononuclear cells (PBMCs) with
IRB approval. PBMCs were isolated by Ficoll-Hypaque
density gradient centrifugation at room temperature.
Non-adherent cells were collected after incubation in
nylon wool for 1 hour at 37°C and were mixed with anti
CD3, CD14, CD19, CD36 and IgE MicroBeads (Milteny-
iBiotec, Auburn, CA) at temperatures between 4–10°C for
the negative selection of NK cells. NK cells with the
CD56+/CD16+  and CD3-  phenotype were negatively
selected at temperatures between 4–10°C and re-exam-
ined by flow-cytometry to ensure purities greater than
90% (Figure 1). Purified NK cells were either treated
immediately with Trizol (Invitrogen, Carlsbad, CA) or
cultured in RPMI 1640 medium (Life Technologies, New
York, NY) supplemented with 10% fetal bovine serum,
200 ug/ml streptomycin and 200 IU/ml penicillin, and
IL2 (100 IU/ml) for 2, 8 or 24 hours at 37°C and 5% CO2,
before harvest and storage in Trizol at -80°C till RNA iso-
lation. Each healthy donor was represented in at least 3BMC Genomics 2007, 8:230 http://www.biomedcentral.com/1471-2164/8/230
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different time points and each time point contained NK
cells from 3 or 4 different donors. For an independent
experiment, NK cells from six new healthy donors were
purified and RNA from at least 3 different donors at each
time point was pooled and hybridized on GeneChipU133
plus 2® (Affymetrix Inc, CA). The purity of NK cells was
determined by two-color flow cytometry with Alexa488-
labeled monoclonal antibody (mAb) against CD3 and
Alexa647-labeled mAb against CD56 or CD16. Of the
negative selected cells 91% to 98% expressed CD56/CD16
but not CD3 (Figure 1). Cytospins of pre- and post puri-
fied PBMCs were stained with Wright-Giemsa stain for
some samples to assess the enrichment of large granular
lymphocytes.
RNA extraction and T7 amplification
Total RNA was extracted with Trizol and further purified
with RNeasy Mini Columns (Qiagen, Valencia, CA) before
aliquots were run in agarose gel electrophoresis and meas-
ured by spectrophotometer at 260 and 280 nm to assess
the quality of the RNA. For each time point, equal
amounts of RNA from at least 3 different healthy donors
were pooled prior to one round of RNA amplification
using MessageAMP™ aRNA kit (Ambion, Austin, TX)
according to the manufacturer's instruction. To minimize
biases in RNA amplification only one round amplifica-
tion was performed and using similar incubations times
and 200 ng of total RNA of good quality as template for
the reverse transcription reaction [56]. The quality and
quantity of aRNA was monitored on agarose gel electro-
phoresis and by spectrophotometer. Typically, 10–20 ug
of aRNA was generated from 200 ng of total RNA by one
round of amplification and 10 ug of aRNA were employed
for hybridization.
Chemical labeling of aRNA
aRNA was chemically labeled with a platinum-linked cya-
nine dye using the MicroMax ASAP RNA labeling kit
(PerkinElmer, Boston, MA) as per the manufactures
instruction. Briefly, 10 ug of aRNA was incubated at 85°C
for 15 minutes with labeling buffer and either Cy5 or Cy3
in a total volume of 20 ul prior to termination of the reac-
tion by cooling on ice and addition of 5 ul of stop buffer.
Labeled aRNA was purified on MicroCon 50 columns
before the final volume was reduced to 3 ul by vacuum
centrifuge (Savant, Farmingdale, NY). aRNA from NK cells
was labeled with Cy5 whereas samples from similarly
amplified lymphoid RNA reference standard, consisting
of RNA from tonsil, thymus, spleen, and cell lines derived
from malignant pre-B cells, plasma cells and NK cells [57]
was labeled with Cy3. Two-color array analyses were used
and determination of expression levels among samples
was based on differences of ratios between sample and ref-
erence. Other reference RNA, including tonsillar, thymus
and resting CD8+T was hybridized for comparative analy-
sis, to obtain a signature for NK cells that is distinctive
from cytotoxic T cells in addition to being distinctive from
a general lymphocyte pool represented by the lymphoid
standard.
Hybridization, washing and scanning
Microarrays with 60-mer oligonucleotides (ONs) (Com-
pugen, Jamesburg, NJ) printed on lysine-coated glass
slides representing 17,260 genes, including reference
(control) genes were utilized for hybridization. Labeled
aRNA from NK cells and the lymphoid standard was com-
bined in 6 ul of deionized water prior to the addition of
poly (dA), human cot-1 DNA and yeast t-RNA at a final
concentration of 10 ug each in a total volume of 45 ul
containing 4.4 × SSC, 4.1 × Denharts and 50% forma-
mide. Hybridization and washing were performed as
described[57]. Arrays were scanned using an Axon 4000
scanner at 10 um resolution and images were analyzed
using Genepix 5.0 software (Axon Instruments, Union
City, CA). Raw gene expression data for spotted oligonu-
cleotide arrays are available at [58](accession number
.GSE8170)
Gene expression profiling with Affymetrix chip 
(GeneChipU133plus 2®)
The isolation of RNA, hybridization and image processing
was performed strictly according to the protocol set up by
Affymetrix (Affymetrix Inc, CA). Briefly, extracted RNA (at
least 2.6 μg used for each time point) was assessed by the
Bio-analyzer 2100 (Agilent Inc, CA), and single round
amplification protocol (one-cycle target labeling kit,
Affymetrix Inc) was utilized for RNA amplification. Anti-
sense biotin-labeled cRNA (10 μg), generated by in vitro
transcription were hybridized and biotinylated probes
hybridized to the array were detected using pycoerythrin
labeled streptavidin. All arrays were scanned using the
Gene-chip scanner 3000 (Affymetrix Inc, CA). The
Affymetrix GeneChip® Operating Software (GCOS) was
utilized for management, sharing, and analysis of data
generated. Other reference RNA was also profiled, namely
lymphoid standard RNA [57], universal RNA standard
and resting CD8+ T cells. The data was analyzed using the
same procedure, as above analysis and only those genes
were selected which show similar trend of expression with
the spotted array data. Raw gene expression data for
affymetrix arrays are available at [58](accession number
GSE8059)
Data analysis
The fluorescent intensity levels corresponding to each
hybridized DNA spot was analyzed with Genepix 5.0 soft-
ware (Axon Instruments, Union City, CA), and hybridized
spots having signal-to-noise ratios below 1.25 and spots
with blemishes were flagged and removed prior to further
analysis. Local background was subtracted from the indi-BMC Genomics 2007, 8:230 http://www.biomedcentral.com/1471-2164/8/230
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vidual spots and intensities for each channel were normal-
ized with respect to median intensity from each channel
for the entire array. The raw expression data from all the
time series were uploaded in BRB-ArrayTools software
(Biometric Research Branch-NCI, MA) and global normal-
ization was used to median center the log-ratios on each
array in order to adjust for differences in labeling intensi-
ties of the Cy3 and Cy5 dyes on different arrays. We
excluded genes from the analysis showing minimal varia-
tion across time series experiments, and genes whose
expression differed by at least 1.25 fold from the median
in at least 20% of the arrays were retained. Adjusted data
were further filtered to remove genes with opposite ratio
values and genes differing more than 3 fold in duplicate
analysis of the same NK sample. For SOM, (self organiz-
ing maps), the weighted average was calculated for each
gene from the duplicate hybridizations according to the
formula μ = Σ (xi/σi
2)/Σ(1/σi
2), where each data point xi is
weighted inversely by its own variance σi
2  [59]. The
weighted average ratio between Cy5 and Cy3 were log2
transformed and arrays from the time series were centered
by resetting the equality parameter (ratio = 1) to the mean
of all the experiments before SOM analysis[60]. SOM, an
artificial intelligence algorithm based on unsupervised
learning configures output vectors into a topological pres-
entation of the original data. Parameters with similar fea-
tures are mapped to the same map unit or nearby units in
a SOM that allows various visual inspections of the clus-
tering of microarray data (additional file 5).
The pathway analysis was performed using the pathway
analytical tool of the BRB-ArrayTools (NCI, NIH-MA)
software [61]. In this tool, two statistics are computed that
summarize the p-values for groups of genes in a pathway;
the Fisher (LS) statistic and the Kolmogorov-Smirnov
(KS) statistic as described [18] We considered a pathway
significant differentially regulated if either significance
level was less than 0.001 or at least 5 genes of a pathway
are represented on the array.
For the supervised pathway analysis, the genes for selected
pathway were downloaded from the Superarray database
(SuperarrayInc, MD) and the from the immune signature
database [19]. The normalized expression of the selected
genes was extracted and differentially expressed genes
were as those that had at least a 2-fold alteration in expres-
sion level between the time points analyzed. Other
selected genes were grouped according to their functional
characteristics available through OMIM database)[62],
Entrez Gene [63] and Pubmed [64]databases. Similar pro-
cedure was used for data analysis on
GeneChipU133plus2® and only those genes were selected
for further analysis which show similar trend of expres-
sion with the spotted array data.
Real time quantitative PCR
To confirm the differential mRNA expression identified by
microarray assay, an independent NK cell isolation, flow
cytometry validation of purity and IL2 stimulation was
performed. A total of 13 genes were selected for validation
by SYBR Green real time quantitative RT-PCR. In brief,
200 ng RNA was reversely transcribed into cDNA with 200
ng random hexamer using MMLV-RNase H- reverse tran-
scriptase as per the manufacturer's instructions (Invitro-
gen, Carlsbad, CA). The human actin, RPL13a and UBC
transcripts were used to normalize the expression levels of
genes across different time points for comparative analy-
sis. The primers were designed to amplify the cDNA close
to the 3' end of the transcript and all the PCR products
were less than 200 bp in length. Quantifications were
done in triplicate and mean values and standard deviation
were calculated for each transcript.
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